A randomised controlled phase I study to determine the safety and immunogenicity of a novel prostate cancer vaccine with and without low dose cyclophosphamide in low and intermediate risk localised prostate cancer

Trial Profile

A randomised controlled phase I study to determine the safety and immunogenicity of a novel prostate cancer vaccine with and without low dose cyclophosphamide in low and intermediate risk localised prostate cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Jan 2018

At a glance

  • Drugs Prostate cancer vaccine (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Jan 2018 Accroding to a Health Research Authority, the phase of the trial as Phase 1 and the other trial details are available at this link: https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/vaccination-in-prostate-cancer-vance-version-10/.
    • 20 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top